106
Views
0
CrossRef citations to date
0
Altmetric
Original Research

In-hospital outcomes of COVID-19 infection in patients with underlying cardiovascular disease

, ORCID Icon, , ORCID Icon, , ORCID Icon, , , ORCID Icon, & show all
Pages 871-876 | Received 26 May 2021, Accepted 27 Jul 2021, Published online: 26 Aug 2021

References

  • Centers for Disease Control and Prevention. Underlying cause of death, 1999–2018. CDC WONDER online database. Atlanta, GA: Centers for Disease Control and Prevention; 2018. [Accessed 2020 Jan 5].
  • Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14(3):247–250.
  • Nishiga M, Wang DW, Han Y, et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543–558.
  • Navar A (2020). Impact of cardiovascular disease on outcomes among hospitalized COVID-19 patients: results from >14,000 patients across the United States. LBS.08, Virtual AHA Scientific Sessions.
  • Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141(20):1648–1655.
  • Bauchner H, Golub RM, Zylke J. Editorial Concern—possible reporting of the same patients with COVID-19 in different reports. JAMA. 2020;323(13):1256.
  • Prasad A, Panhwar S, Hendel RC, et al. COVID-19 and the cardiovascular system: a review of current data, summary of best practices, outline of controversies, and illustrative case reports. Am Heart J. 2020;226:174–187.
  • Guan W-J, Ni Z-Y, Hu Y, et al. China medical treatment expert group for Covid-19 (2020) clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
  • Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — united States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):759–765.
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943.
  • Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol. 2020;30(3):e2103.
  • Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically Ill patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614.
  • Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372–2374.
  • the Northwell COVID-19 Research Consortium, Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059.
  • Rosenberg ES, Dufort EM, Blog DS, et al., New York State Coronavirus. Response Team (2020) COVID-19 testing, epidemic features, hospital outcomes, and household prevalence, New York State—March 2020. Clin Infect Dis. 2019;71(8):1953–1959.
  • Lavery AM, Preston LE, Ko JY, et al. Characteristics of hospitalized COVID-19 patients discharged and experiencing same-hospital readmission - United States, March-August. MMWR Morb Mortal Wkly Rep. 2020;69(45):1695–1699.
  • Bhatt AS, Moscone A, McElrath EE, et al. Fewer Hospitalizations For Acute Cardiovascular Conditions During the COVID-19 pandemic. J Am Coll Cardiol. 2020;76(3):280–288.
  • Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818.
  • Sandoval Y, Januzzi JL, Jaffe AS. Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244–1258.
  • Giustino G, Croft LB, Stefanini GG, et al. Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. 2020;76:2043–2055. CrossrefMedlineGoogle Scholar.
  • Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802–810. CrossrefMedlineGoogle Scholar.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062.
  • Hofmann H, Pyrc K, van der Hoek L, et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA. 2005;102:7988–7993. CrossrefMedlineGoogleScholar.
  • Ge XY, Li JL, Yang XL, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535–538.
  • Bilaloglu S, Aphinyanaphongs Y, Jones S, et al. Thrombosis in hospitalized patients with COVID-19 in a New York city health system. JAMA. 2020;324:799–801. CrossrefMedlineGoogle Scholar.
  • Elbadawi A, Elgendy IY, Sahai A, et al. Incidence and outcomes of thrombotic events in symptomatic patients with COVID-19. Arterioscler Thromb Vasc Biol. 2020;41:545–547.
  • Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821–1829.
  • Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329–336.
  • Fumagalli S, Salani B, Gabbani L, et al. Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? Eur J Intern Med. 2020;77:141–142.
  • Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776.
  • Coromilas EJ, Kochav S, Goldenthal I, et al. Worldwide survey of COVID-19-associated arrhythmias. Circ Arrhythm Electrophysiol. 2021;14(3):e009458.
  • Gurfinkel EP, Leon de la Fuente R, Mendiz O, et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J. 2004;25(1):25–31.
  • Gurfinkel EP, de la Fuente RL. Two-year follow-up of the FLU vaccination acute coronary syndromes (FLUVACS) registry. Tex Heart Inst J. 2004;31(1):28–32.
  • Davis JW, Lee E, Taira DA, et al. Influenza vaccination, hospitalizations, and costs among members of a medicare managed care plan. Med Care. 2001;39(12):1273–1280.
  • Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158(16):1769–1776.
  • Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102(25):3039–3045.
  • Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction [published correction appears in Stroke. 2002;33:1171]. Stroke. 2002;33(2):513–518.
  • Siscovick DS. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000;152(7):674–677.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.